UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Studies on hemostasis in COVID‐19 deserve careful reporting of the laboratory methods, their significance, and their limitations

Journal of thrombosis and haemostasis, 2020-11, Vol.18 (11), p.3121-3124

2020

Volltextzugriff (PDF)

Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability

Journal of thrombosis and haemostasis, 2019-10, Vol.17 (10), p.1670-1682

2019

Volltextzugriff (PDF)

Comparisons between diluted thrombin time, ecarin chromogenic assays, and UPLC–MS for plasma level dabigatran quantification: Results from DRIVING study

International Journal of Laboratory Hematology, 2024-02, Vol.46 (1), p.120-127

2024

Volltextzugriff (PDF)

Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months

International Journal of Laboratory Hematology, 2021-08, Vol.43 (4), p.821-830

2021

Volltextzugriff (PDF)

Heparin‐induced thrombocytopenia leading to a diagnosis of essential thrombocythemia

International Journal of Laboratory Hematology, 2021-08, Vol.43 (4), p.O193-O196

2021

Volltextzugriff (PDF)

P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation

International journal of molecular sciences, 2020-02, Vol.21 (4), p.1391

2020

Volltextzugriff (PDF)

Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection

Virology journal, 2021-10, Vol.18 (1), p.1-211, Article 211

2021

Volltextzugriff (PDF)

A performance evaluation of sthemO 301 coagulation analyzer and associated reagents

Journal of clinical laboratory analysis, 2023-06, Vol.37 (11-12), p.e24929-n/a

2023

Volltextzugriff (PDF)

Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations

Pharmaceutics, 2023-02, Vol.15 (2), p.665

2023

Volltextzugriff (PDF)

Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant–treated patients

Clinical cardiology (Mahwah, N.J.), 2018-05, Vol.41 (5), p.646-651

2018

Volltextzugriff (PDF)

Optimizing the Use of Anticoagulants (Heparins and Oral Anticoagulants) in the Elderly

Drugs & aging, 2013-09, Vol.30 (9), p.687-699

2013

Volltextzugriff (PDF)

Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation

Journal of clinical medicine, 2020-07, Vol.9 (8), p.2361

2020

Volltextzugriff (PDF)

Improving Anticoagulation Control in Hospitalized Elderly Patients on Warfarin

Journal of the American Geriatrics Society (JAGS), 2010-02, Vol.58 (2), p.242-247

2010

Volltextzugriff (PDF)

Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor

TH open : companion journal to thrombosis and haemostasis, 2021-04, Vol.5 (2), p.e163-e165

2021

Volltextzugriff (PDF)

Reversal of Overanticoagulation in Very Elderly Hospitalized Patients with an INR above 5.0: 24-Hour INR Response after Vitamin K Administration

The American journal of medicine, 2011-06, Vol.124 (6), p.527-533

2011

Volltextzugriff (PDF)

A need for evidence-based clinical practice guidelines for the use of heparins in the elderly

Clinical interventions in aging, 2010-01, Vol.5, p.119-121

2010

Volltextzugriff (PDF)

Competition of unfractionated heparin and idraparinux on activated partial thromboplastin time and effect of exogenous antithrombin

Thrombosis and haemostasis, 2009-05, Vol.101 (5), p.986

2009

Volltextzugriff (PDF)

Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants

Thrombosis research, 2019-12, Vol.184, p.86-91

2019

Volltextzugriff (PDF)

“Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis”: comment from Gouin-Thibault et al

Journal of thrombosis and haemostasis, 2024-02, Vol.22 (2), p.572-574

2024

Volltextzugriff (PDF)

Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis

Archives of cardiovascular diseases, 2011-12, Vol.104 (12), p.669-676

2011

Volltextzugriff (PDF)

P2Y Inhibition beyond Thrombosis Effects on Inflammation

International journal of molecular sciences, 2020-02, Vol.21 (4)

2020

Volltextzugriff (PDF)

European guidelines on peri-operative venous thromboembolism prophylaxis: first update: Chapter 10: Surgery in the obese patient

European journal of anaesthesiology, 2024-08, Vol.41 (8), p.607-611

2024

Volltextzugriff (PDF)

2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

Thrombosis and haemostasis, 2021-08, Vol.121 (8), p.1008

2021

Volltextzugriff (PDF)

European guidelines on peri-operative venous thromboembolism prophylaxis: first update

European journal of anaesthesiology, 2024, Vol.41 (8), p.607-611

2024

Volltextzugriff (PDF)

Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study

European heart journal, 2017-08, Vol.38 (31), p.2431-2439

2017

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(90)

Publikationsform

Artikel
(110)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(72)
Science & Technology
(72)
Humans
(57)
Life Sciences
(42)
Aged
(27)
Hematology
(26)
Cardiovascular System & Cardiology
(25)
Female
(22)
Male
(22)
Aged, 80 And Over
(21)
Peripheral Vascular Disease
(20)
Anticoagulants - Therapeutic Use
(15)
Biological And Medical Sciences
(15)
Anticoagulants - Administration & Dosage
(14)
Anesthesiology
(13)
Anticoagulants - Adverse Effects
(13)
Medical Sciences
(13)
Middle Aged
(12)
Administration, Oral
(11)
Medical Laboratory Technology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Studies on hemostasis in COVID‐19 deserve careful reporting of the laboratory methods, their significance, and their limitations

Rivaroxaban pharmacodynamics in healthy volunteers evaluated with thrombin generation and the active protein C system: Modeling and assessing interindividual variability

Comparisons between diluted thrombin time, ecarin chromogenic assays, and UPLC–MS for plasma level dabigatran quantification: Results from DRIVING study

Study of thrombin generation with St Genesia to evaluate xaban pharmacodynamics: Analytical performances over 18 months

Heparin‐induced thrombocytopenia leading to a diagnosis of essential thrombocythemia

P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation

Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection

A performance evaluation of sthemO 301 coagulation analyzer and associated reagents

Transferability of Published Population Pharmacokinetic Models for Apixaban and Rivaroxaban to Subjects with Obesity Treated for Venous Thromboembolism: A Systematic Review and External Evaluations

Periprocedural management of anticoagulation for atrial fibrillation catheter ablation in direct oral anticoagulant–treated patients

Optimizing the Use of Anticoagulants (Heparins and Oral Anticoagulants) in the Elderly

Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation

Improving Anticoagulation Control in Hospitalized Elderly Patients on Warfarin

Management of a High-Risk Surgery with Emicizumab and Factor VIII in a Child with a Severe Hemophilia A and Inhibitor

Reversal of Overanticoagulation in Very Elderly Hospitalized Patients with an INR above 5.0: 24-Hour INR Response after Vitamin K Administration

A need for evidence-based clinical practice guidelines for the use of heparins in the elderly

Competition of unfractionated heparin and idraparinux on activated partial thromboplastin time and effect of exogenous antithrombin

Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants

“Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis”: comment from Gouin-Thibault et al

Surgery and invasive procedures in patients on long-term treatment with direct oral anticoagulants: Thrombin or factor-Xa inhibitors. Recommendations of the Working Group on perioperative haemostasis and the French Study Group on thrombosis and haemostasis

P2Y Inhibition beyond Thrombosis Effects on Inflammation

European guidelines on peri-operative venous thromboembolism prophylaxis: first update: Chapter 10: Surgery in the obese patient

2021 Update of the International Council for Standardization in Haematology Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

European guidelines on peri-operative venous thromboembolism prophylaxis: first update

Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study

Suchergebnisse filtern